Quantitative SARS-CoV-2 anti-spike responses to Pfizer–BioNTech and Oxford–AstraZeneca vaccines by previous infection status

Quantitative SARS-CoV-2 anti-spike responses to Pfizer–BioNTech and Oxford–AstraZeneca vaccines by previous infection status

<p><strong>Objectives</strong> We investigated determinants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) anti-spike IgG responses in healthcare workers (HCWs) following one or two doses of Pfizer–BioNTech or Oxford–AstraZeneca vaccines.</p> <p><st...

Full description

Bibliographic Details
Main Authors: Eyre, DW, Lumley, SF, Wei, J, Cox, S, James, T, Justice, A, Jesuthasan, G, O'Donnell, D, Howarth, A, Hatch, SB, Marsden, BD, Jones, EY, Stuart, DI, Ebner, D, Hoosdally, S, Crook, DW, Peto, TEA, Walker, TM, Stoesser, NE, Matthews, PC, Pouwels, KB, Walker, AS, Jeffery, K
Format: Journal article
Language:English
Published: Elsevier 2021

Similar Items